*In vitro* culture of preimplantation embryos is an essential step in assisted reproductive technology (ART) for both human and animals \[[@r1], [@r2]\], which is now considered to be a part of mainstream medical practice. However, the birth rate of offspring following ART still lags behind that of their *in vivo* counterparts, with only a certain percentage of *in vitro*-cultured (IVC) embryos being capable of establishing pregnancy after their transfer into recipients \[[@r3]\]. Moreover, the *in vitro* culture environment is known to determine embryo quality \[[@r4]\], with the latter being the main reason for decreased developmental competence of IVC embryos after transplantation \[[@r5]\]. Therefore, ongoing efforts have focused on modifying culture conditions to get high-quality embryos, and evaluating cultured embryos in terms of morphology and gene expression.

*Scutellaria baicalensis* as a traditional Chinese herbal medicine is used as an anti-abortive, anti-inflammatory, and anti-bacterial drug \[[@r6]\] for the treatment of pregnant women \[[@r7], [@r8]\]. Baicalin, a monomer of flavonoids, extracted from dried roots of *S. baicalensis* \[[@r9]\], also shows anti-abortive properties as it modulates the Th1/Th2 cytokine balance, promotes mouse embryo implantation \[[@r10]\], and protects pregnant mice from abortion induced by lipopolysaccharide \[[@r11]\]. Additionally, baicalin is the active ingredient in Shuanghuanglian oral liquid, an antipyretic detoxicant widely used for pregnant women and animals in China \[[@r12]\]. Although it has been clinically shown that baicalin can help maintain pregnancy in both humans \[[@r8]\] and mice \[[@r13]\], little information has been presented to explain how baicalin enhances developmental competence of mouse embryos *in vitro*.

It is well documented that gene expression of the embryo can be altered by the culture conditions, which in turn affects embryo development \[[@r5], [@r14]\]. Previously, it has been reported that *in vitro* culture conditions can lead to increased incidence of cellular stress and apoptosis \[[@r15], [@r16]\] and induce aberrant DNA methylation in mouse embryos \[[@r17], [@r18]\], both of which may result in decreased blastocyst quality and even affect the viability of offspring after transfer into a surrogate. Gene expression analysis, a preferred method over conventional criteria like embryo morphology and developmental rates \[[@r19]\], has commonly been used to assess embryo quality and to optimize *in vitro* culture conditions \[[@r20]\]. Therefore, in this study, a group of marker genes related to cellular stress and apoptosis, and DNA methylation were measured to explore the regulatory mechanism of baicalin in developmental competence of mouse embryos *in vitro*.

Materials and Methods {#s1}
=====================

Reagents and animals
--------------------

All chemicals used in this study were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless otherwise stated. Baicalin (concentration ≥ 98%) was bought from the National Pharmaceutical Engineering Center (Jiangxi, China). Both, pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG), were obtained from Ningbo Sansheng Pharmaceutical (Ningbo, China). Goat polyclonal anti-HSP70 (sc-1060), rabbit polyclonal anti-BCL-2 (sc-492), and anti-BAX (sc-526) antibodies were obtained from Santa Cruz Biotechnology (USA), while rabbit polyclonal anti- Caspase-3 (ab-90437) antibodies were obtained from Abcam (Cambridge, UK). Secondary polyclonal anti-goat and anti-rabbit fluorescein isothiocyanate-conjugated antibodies were purchased from Jackson ImmunoResearch Laboratories (USA). Sexually mature Kunming mice of both sexes (5--6 weeks old, with average body weight of 25 g) were purchased from the Experimental Animal Center of Shandong University. The mice were housed under a light-dark cycle of 12/12 h at approximately 23ºC with food and water provided *ad libitum*, after purchase. All mouse manipulations were performed with the approval of the Animal Care and Ethics Committee of Qingdao Agricultural University.

Embryo collection and culture
-----------------------------

Female mice were injected intraperitoneally with 10 IU of PMSG, followed by 10 IU hCG 48 h later, for superovulation and were allowed to mate overnight. After 40, 64, 72, and 96 h post-hCG injection, the embryos in their 2- and 4-cell, morula and blastocyst stage, respectively, were flushed directly from the oviducts, and used as the *in vivo* control group. All embryos were rinsed with phosphate-buffered saline (PBS) and stored at --80ºC.

Superovulation of mice was conducted as described previously, and pronuclear embryos flushed from the oviducts, after 28 h post-hCG injection, were treated with hyaluronidase (1 mg/ml) to remove cumulus cells and were washed three times with PBS for subsequent culture *in vitro*. Pronuclear embryos were cultured in KSOM culture medium, and used as the *in vitro*-cultured control group (n = 246).

Baicalin was dissolved in KSOM culture medium. The pronuclear embryos cultured in KSOM medium supplemented with 2 (n = 204), 4 (n = 210), and 8 μg/ml (n = 201) of baicalin, respectively, for 96 h up to the blastocyst stage were used for the baicalin treatment groups. Each of the above-mentioned groups' pronuclear embryos were cultured in 50 μl KSOM culture medium droplets, covered with mineral oil and cultured *in vitro* at 37ºC, 5.0% CO~2~, and 100% saturated humidity. The developmental rates for each stage of the embryos in each group were recorded every 24 h.

Blastocyst cell count
---------------------

Blastocysts (n = 45) from each group were fixed in 4% (w/v) paraformaldehyde at room temperature (20--25ºC) for 30 min and washed with PBS containing 0.4% polyvinyl alcohol (PBS-PVA) three times, and permeabilized with PVA-PBS containing 1% TritonX-100 at room temperature for 40 min and washed with PVA-PBS three times. Then, the nuclei of blastocysts were stained with propidium iodide (PI, 10 μg/ml) in PVA-PBS at 37ºC for 10 min and the number of cells were counted using a fluorescence microscope.

Quantitative PCR
----------------

The total RNA was extracted from 50 blastocysts using RNeasy Micro Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The purity and quantity of extracted RNA were determined using Biophotometer Plus (Eppendorf, Hamburg, Germany). The synthesis of cDNA was performed with 500 ng total RNA using First Strand cDNA Synthesis Kit (Fermentas, Waltham, USA). The levels of mRNA were measured by real-time PCR using SYBR Green I and the Light Cycler480 System (Roche Diagnostics, Basel, Switzerland). Each PCR mixture consisted of 2 µl of cDNA, 10 µl of SYBR Green PCR Master Mix (Roche), 1 µl of sense primer, and 1 µl of antisense primer (Sangon Biotech, Shanghai, China, [Table 1](#tbl_001){ref-type="table"}Table 1.Primer sequences used for the q-PCR assayGenePrimer sequencesPCR product size (bp)GenBank \[No.\]*CDH1*AACCCAAGCACGTATCAGGG142NM_009864.2ACTGCTGGTCAGGATCGTTG*GJA1*CCCACCTTTGTGTCTTCCAT151NM_010288.3TTGCCTCCCTGATGCTAACT*HSP70*TGTGTCGGGTCCTTCAGAG130NM_010479.2CACCTCCAAGTTCACCAACC*BAX*CGTGGTTGCCCTCTTCTACT110XM_006540584.1CACGGAGGAAGTCCAGTGTC*BCL-2*CGACTTCTTCAGCATCAGGA103NM_009741.4TGAGCCACAGGGAGGTTCT*DNMT1*TGGTGTTGTCTACCGACTGG118NM_001199431.1CAGGGTCTCGTTCACAGGAT*DNMT3a*TCCAAGACACCGCTAAGGTT129NM_007872.4TGAATCCCTACCAGCAAAGG*GAPDH*ACGGCACAGTCAAGGCAGAG183NM_008084GTGATGGCGTGGACAGTGGT) in a final volume of 20 µl. They were then subjected to the following conditions: 95ºC for 10 min, followed by 45 cycles at 95ºC for 10 sec, 60ºC for 30 sec, 72ºC for 60 sec in 96-well optical reaction plates (Roche), and the melting curves were analyzed at 65ºC and 97ºC after 45 cycles. Transcript levels presented for each gene were normalized to GAPDH levels, and the 2^−ΔΔCt^ method was used to calculate mRNA levels, as reported by Schmittgen \[[@r21]\].

Apoptosis assays
----------------

Blastocysts (n = 30) from the *in vitro* baicalin-treated and *in vivo* groups were stained with Hoechst 33342 (10 ng/ml) for 10 min and then washed three times in PBS before being mounted and examined using a fluorescence microscope.

Immunostaining
--------------

Blastocysts were fixed in 4% paraformaldehyde for 30 min and were permeabilized with PBS containing 1% Triton X-100 for 40 min at 25°C. They were then incubated in PBS containing 1.0% bovine serum albumin at 37°C for 1 h. The blastocysts were subsequently incubated overnight at 4°C with primary antibody (1:100 dilution) against HSP70, BAX, BCL-2, and CASP3. They were further incubated with secondary polyclonal anti-goat or anti-rabbit IgG (1:400 dilution) at 25°C for 1 h. The blastocysts were finally stained with PI at 37°C for 10 min, mounted onto slides, and examined using a confocal microscope.

Statistical analysis
--------------------

All data were presented as mean ± standard deviation (SD) of at least three independent experiments. Differences between groups were evaluated by one-way ANOVA, followed by Tukey and Dunnett's t-test using Graphpad Prism 5.01 (GraphPad Software). A difference at P *\<* 0.05 was considered statistically significant.

Results {#s2}
=======

Effects of baicalin on the development of mouse embryos in vitro
----------------------------------------------------------------

We observed that IVC embryos exhibited lower blastocyst developmental rates compared to the *in vivo* control group; however, baicalin increased these rates in IVC embryos as compared to the *in vitro* control group. The percentage of embryos that developed to the 2-cell stage were 92.6, 95.7, and 80.5% for the 2-, 4-, and 8-µg/ml baicalin treatment groups, respectively, compared to 89.6% in the *in vitro* control group (0.0 µg/ml baicalin; [Table 2](#tbl_002){ref-type="table"}Table 2.Effect of different concentrations of baicalin on the development of mouse embryos *in vitro*Baicalin (µg/ml)No. of 1-cell embryos2-cell rate (%)4-cell rate (%)Morula rate (%)Blastocyst rate (%)*In vivo* control--97 ± 1.19 ^Aa^96 ± 2.43 ^A^94.7 ± 3.87 ^A^90.3 ± 5.07 ^A^08289.6 ± 4.56 ^Bb^82.1 ± 3.87 ^B^70.1 ± 2.05 ^Ba^53.7 ± 3.45 ^Ba^26892.6 ± 2.87 ^BCc^86.2 ± 3.36 ^B^80.4 ± 4.74 ^C^63.8 ± 2.56 ^C^47095.7 ± 4.40 ^ACa^92.9 ± 3.98 ^A^88.6 ± 5.32 ^D^78.6 ± 4.08 ^D^86780.5 ± 3.34 ^D^72.0 ± 5.08 ^C^68.3 ± 4.00 ^Ea^50.0 ± 4.32 ^Ea^Different uppercase or lowercase letters in a column represent significant differences of P \< 0.01 and P \< 0.05, respectively.). The percentage of embryos that developed to the 4-cell stage were significantly higher (P *\<* 0.01) in the 2- and 4- µg/ml baicalin treatment groups and lower (P *\<* 0.01) in the 8-µg/ml baicalin treatment group, compared to the *in vitro* control group ([Table 2](#tbl_002){ref-type="table"}). Both morula and blastocyst developmental rates were significantly higher (P *\<* 0.01) in 2-µg/ml and 4-µg/ml baicalin treatment group compared to the *in vitro* control group. Meanwhile, the blastocyst developmental rate in the 4-µg/ml baicalin group was significantly higher (P *\<* 0.01) than that in the 2-µg/ml baicalin group ([Table 2](#tbl_002){ref-type="table"}). Furthermore, the number of blastocyst cells in the 4-µg/ml baicalin treatment group (59.93%) was significantly (P *\<* 0.01) higher than those *in vitro* control group (50.98%) ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Effect of different concentrations of baicalin on cell number of blastocyst *in vitro*. The nuclei of the blastocysts were stained with PI and the cell numbers were counted using a fluorescence microscope. \* P *\<* 0.05 *vs*. *in vivo* control group and \*\* P *\<* 0.01 *vs*. *in vivo* control group; ^\#^ P *\<* 0.05 *vs*. IVC group and ^\#\#^ P *\<* 0.01 *vs*. IVC group.). Based on the above results, the dose of 4 µg/ml baicalin was used for subsequent experiments.

Effect of baicalin on gene expression levels of developmentally important genes in mouse embryos
------------------------------------------------------------------------------------------------

We observed that the mRNA expression levels of both, gap junction protein alpha 1 (*Gja1*) ([Fig. 2-A](#fig_002){ref-type="fig"}Fig. 2.Developmentally important genes measured by q-PCR. Expressions of *Gja1*, *Cdh1*, *Dnmt1* and *Dnmt3a* genes in mouse blastocysts from the *in vitro*, baicalin-treated, and *in vivo* groups were measured to examine the effect of baicalin on mouse blastocyst quality. \* P *\<* 0.05 *vs*. *in vivo* control group and \*\* P *\<* 0.01 *vs*. *in vivo* control group; ^\#^ P *\<* 0.05 *vs*. IVC group and ^\#\#^ P *\<* 0.01 *vs*. IVC group.) and E-cadherin (*Cdh1*) ([Fig. 2-B](#fig_002){ref-type="fig"}), in IVC blastocysts were significantly decreased (P *\<* 0.01) compared to the *in vivo* control group. However, their mRNA expression levels were significantly increased (P *\<* 0.01 for *Gja1* and P *\<* 0.05 for *Cdh1*) in the baicalin-treated blastocysts compared to the *in vitro* control group.

The mRNA expression level of DNA methyltransferases 1 (*Dnmt1*) ([Fig. 2-C](#fig_002){ref-type="fig"}) in IVC blastocysts was significantly increased (P *\<* 0.05) compared to the *in vivo* control group. Moreover, its expression was significantly decreased (P *\<* 0.01) in the baicalin-treated blastocysts compared to the *in vitro* control group. However, DNA methyltransferases 3a (*Dnmt3a*) mRNA expression ([Fig. 2-D](#fig_002){ref-type="fig"}) in IVC control blastocysts was lower (P \> 0.05) compared to the *in vivo* control group, while it was higher (P *\<* 0.01) in baicalin-treated blastocysts compared to the *in vitro* control group and the *in vivo* control group (P *\<* 0.05).

Effect of baicalin on cellular stress in mouse embryos
------------------------------------------------------

Heat Shock Protein 70 (*Hsp70*) mRNA and protein levels were determined by qPCR and immunostaining, respectively, to investigate the effect of baicalin on cellular stress in mouse blastocysts *in vitro*. We observed that mRNA expression of *Hsp70* in IVC blastocysts was significantly increased (P *\<* 0.01) compared to the *in vivo* control group, while it was significantly decreased (P *\<* 0.01) in the baicalin-treated blastocysts compared to the *in vitro* control group. Consistent with the data on mRNA expression, weaker expression of HSP70 protein was observed in the baicalin-treated blastocysts than the *in vitro* control group ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Relative *Hsp70* gene and its protein (by immunostaining) expressions in mouse blastocysts (n = 30) from the *in vitro*, baicalin-treated, and *in vivo* groups. \* P *\<* 0.05 *vs*. *in vivo* control group and \*\* P *\<* 0.01 *vs*. *in vivo* control group; ^\#^ P *\<* 0.05 *vs*. IVC group and ^\#\#^ P *\<* 0.01 *vs*. IVC group.).

Effect of baicalin on cellular apoptosis in mouse embryos
---------------------------------------------------------

The blastocyst nuclei, stained with high-density fluorescence, showed fragmented or condensed morphology ([Fig. 4-A](#fig_004){ref-type="fig"}Fig. 4.Effect of baicalin on cellular apoptosis in mouse embryos. The nuclei of blastocysts (n = 30) were stained with Hoechst 33342 to examine cell apoptosis (Bar = 100 μm). Blastocysts from the *in vitro* (left), baicalin-treated (middle), and *in vivo* (right) groups showing higher degree of apoptosis of nuclei for *in vitro* group (white arrows) than the baicalin treated or *in vivo* group (A). Relative mRNA and protein expression levels of Caspase-3 (B), BAX (C) and BCL-2 (D), respectively, in mouse blastocysts (n = 30) from the *in vitro*, baicalin treated and *in vivo* groups. \* P *\<* 0.05 *vs*. *in vivo* control group and \*\* P *\<* 0.01 *vs*. *in vivo* control group; ^\#^ P *\<* 0.05 *vs*. IVC group and ^\#\#^ P *\<* 0.01 *vs*. IVC group., left) suggesting apoptosis. Baicalin-treated blastocysts had fewer apoptotic nuclei compared to the IVC blastocysts, while the *in vivo* group had the least. Cysteinyl aspartate specific protease-3 (*Casp3*), B-cell lymphoma protein 2 (*Bcl-2*), and BCL-2-associated X protein (*B*ax) mRNA and protein levels were determined by qPCR and immunostaining, respectively, to investigate the effect of baicalin on cellular apoptosis in mouse blastocysts *in vitro*. We found that the mRNA expression levels of *Casp3* ([Fig. 4-B](#fig_004){ref-type="fig"}) and *Bax* ([Fig. 4-C](#fig_004){ref-type="fig"}) in IVC blastocysts were significantly increased (P *\<* 0.01) compared to the *in vivo* control group. However, they were significantly decreased (P *\<* 0.05) in the baicalin-treated blastocysts compared to the *in vitro* control group. Moreover, *Bcl-2* mRNA expression of IVC control blastocysts was significantly decreased (P *\<* 0.01) compared to the *in vivo* control group, while, its expression was significantly increased (P *\<* 0.05) in the baicalin-treated blastocysts compared to the *in vitro* control group ([Fig. 4-D](#fig_004){ref-type="fig"}). Consistent with the data on mRNA expression, weaker protein expression of CASP3 ([Fig. 4-B](#fig_004){ref-type="fig"}) and BAX ([Fig. 4-C](#fig_004){ref-type="fig"}) were observed in the baicalin-treated blastocysts than in the *in vitro* control group, while BCL-2 protein expression ([Fig. 4-D](#fig_004){ref-type="fig"}) was higher in the baicalin-treated blastocysts compared to the *in vitro* control group.

Discussion {#s3}
==========

Previous studies have shown that the embryo quality and viability is mainly affected by *in vitro* culture conditions \[[@r4], [@r22],[@r23],[@r24]\], and high-quality embryos can be achieved through modifying culture conditions \[[@r24], [@r25]\]. Baicalin has been reported to promote embryo implantation and maintain pregnancy in mice \[[@r13]\]. This study has demonstrated that baicalin increased 2- and 4-cell embryonic cleavage rates, morula and blastocyst developmental rates, and promoted proliferation of mouse blastocysts cultured *in vitro*. Consequently, the percentage of mouse embryos that developed to the blastocyst stage increased compared to that reported for the IVC control group. Similarly, Sun *et al*. demonstrated that baicalin increased mouse blastocyst-hatching rates, and number of hatched blastocysts by inhibiting malondialdehyde (MDA) formation under culture condition \[[@r26]\]. Furthermore, Gao *et al*. have reported that baicalin increased pregnancy rates and fetal survival rates following transplantation of IVC blastocysts with no side effects on neonatal mice \[[@r27]\].

Apart from morphological criteria, expression levels of developmentally important genes have also been monitored to assess blastocyst quality \[[@r4], [@r20]\], which may explain how baicalin improves developmental competence of mouse embryos *in vitro*. The level of *Gja1* mRNA, which is one of the gap junction proteins, has been shown to be higher in *in vivo* derived mouse and bovine blastocysts compared to those produced *in vitro* \[[@r15], [@r28]\], which is consistent with the higher quality blastocysts recorded in terms of cryotolerance \[[@r29]\]. Cell adhesion molecule *Cdh1* has been reported to mediate the compaction process of morula and regulate subsequent blastocyst formation in mouse \[[@r30]\]. In the present study, baicalin increased *Gja1* and *Cdh1* gene expression in IVC embryos, which coincided with the higher blastocyst formation rates, similar to the injection of *GJA1* or *CDH1* double-stranded RNA into bovine zygotes decreased the percentage of zygotes developing to blastocyst by 18.4 and 16.3% *in vitro*, respectively \[[@r31]\]. It has also been reported that both *CDH1* and *GJA1* mRNA expression levels are positively correlated with the quality of bovine blastocysts \[[@r24]\]. Our results indicate that baicalin promotes *in vitro* development of mouse embryos by up-regulating *Gja1* and *Cdh1* gene expression.

It has been suggested that the *in vitro*-culture environment increases embryonic cellular stress and apoptosis \[[@r32]\], and embryos adapt to these conditions by adjusting their developmental program \[[@r22]\]. *HSP70* is one of the earliest genes that is constitutively expressed in early embryonic development after the activation of the embryo's transcriptome \[[@r33]\], and it was found that induced thermo-tolerance occurred significantly earlier in *in vitro*-cultured *vs*. *in vivo*-generated murine embryos \[[@r34]\]. Additionally, *Hsp70.1* gene expression in IVC 2-cell stage embryos is 15 times higher than that in *in vivo*-collected 2-cell mouse embryos \[[@r33]\], as well as the blastocyst stage onward \[[@r35]\]. So, it has often been used to assess stress response in IVC embryos \[[@r36], [@r37]\]. Our observations that baicalin inhibited *Hsp70* gene expression in *in vitro* culture may provide an explanation to how baicalin increases developmental competence of mouse embryos *in vitro*, because the up-regulated *Hsp70* mRNA level, indicates increased embryonic stress and in turn IVC embryos decrease their blastocyst developmental rate \[[@r32]\]. However, it is not clear how baicalin inhibits *Hsp70* gene expression in IVC mouse embryos, with a possibility that baicalin optimizes culture environment and reduces embryonic stress.

Apoptosis is an important physiological process for eliminating mutated or damaged cells under stressed condition \[[@r38]\], and the increased incidence of apoptosis in embryonic cells indicates the poor quality of IVC embryos \[[@r16]\]. It has been reported that apoptosis is more frequent in *in vitro* than in *in vivo* produced blastocysts \[[@r39]\]. In our study, baicalin reduced *Bax* and *Bcl-2* gene expression in IVC embryos, suggesting an anti-apoptotic effect of baicalin, which protected embryos from apoptosis induced by *in vitro* culture conditions. Baicalin has also been reported to protect against heat-stress-induced apoptosis \[[@r40]\], and to decrease cellular apoptosis rates through down-regulation of *BAX* expression in bovine Sertoli cells \[[@r41]\]. Moreover, good-quality bovine blastocysts have lower *HSP70* and *BAX* \[[@r42], [@r43]\] and higher *BCL-2* mRNA levels compared to poor-quality embryos \[[@r38]\]. Our results indicate that baicalin increases developmental competence of mouse embryos *in vitro* by reducing cellular stress by inhibiting cellular apoptosis and *Hsp70* expression.

DNA methylation, a mechanism of epigenetic reprogramming of the genome during embryogenesis \[[@r44],[@r45],[@r46]\], is accomplished through the activities of DNA methyltransferases (DNMTs) \[[@r47]\], which mainly focuses on two different methylation processes: maintenance and *de novo*, and are catalyzed by DNMT1 and DNMT3a, respectively \[[@r48]\]. The DNMT gene appears to be affected by *in vitro* culture conditions, which may result in aberrant DNA methylation \[[@r48], [@r49]\]. Our results in mice and those in bovine \[[@r17]\] and rabbit \[[@r49]\] preimplantation embryos demonstrate that IVC embryos show increased *DNMT1* gene expression. Huan *et al*. also found that DNA methylation inhibitor (5-aza-dC, 5-Aza-2′-deoxycytidine) enhances development of porcine cloned embryos accompanied with lower *DNMT1* and higher *DNMT3a* gene expression \[[@r50]\]. Interestingly, we found decreased *Dnmt1* and increased *Dnmt3a* gene expressions following baicalin treatment of IVC embryos. Although the mechanism behind baicalin-induced up-regulation of *Dnmt3a* gene expression is unclear, higher *Dnmt3a* mRNA levels in mouse blastocyst than its early developmental stage to establish a new embryonic methylation pattern have been reported \[[@r47]\]. Moreover, the beneficial effects of melatonin on bovine embryo-quality have also been shown to be due to the increased *DNMT3a* gene expression \[[@r25]\]. Our study indicates that baicalin enhances developmental competence of mouse embryos *in vitro* via down-regulating *Dnmt1* and up-regulating *Dnmt3a* gene expressions to improve DNA methylation.

In summary, this study indicates that *in vitro* culture conditions adversely affect blastocyst quality through modifications in the expression of developmentally important genes. However, baicalin improved the developmental competence of embryos and blastocyst-quality, to a level intermediate between IVC blastocysts and those derived *in vivo*, by improving the blastocyst developmental rates and DNA methylation, and inhibiting cellular apoptosis and *HSP70* expression. This study provides a rudimentary experimental basis for the use of baicalin to optimize embryonic culture medium or to maintain pregnancy in female animals. However, considering the limitations of an *in vitro* study further investigation is necessary to confirm the protective effect of baicalin *in vivo*.
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